Evidence map›Paper›PMID 36037133›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2022

Prevalence and Predictors of Cervical Cancer Screening among Reproductive Age Group Women: Evidence from Cross-Sectional Study in Rohtak and Delhi.

Shobhit Srivastava, Kauma Kurian, Priyanka Rani Garg, Ataur Rehman, Rishi Garg, Suresh Kumar Rathi, Sunil Mehra

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shobhit SrivastavaMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.ORCID 0000-0002-7138-4916
Kauma KurianMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.ORCID 0000-0003-1287-1404
Priyanka Rani GargMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.ORCID 0000-0002-9752-8762
Ataur RehmanMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.
Rishi GargMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.
Suresh Kumar RathiMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.ORCID 0000-0002-8480-1627
Sunil MehraMAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave II, New Delhi, India.ORCID 0000-0001-7414-7054
Mamta Health Institute for Mother and Child · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study aims to estimate the prevalence and determine the factors for cervical cancer screening among women in the reproductive age group in Delhi and Rohtak, India.

methodsThe data were utilized from a survey conducted as part of a larger study to increase the access to cervical cancer screening and care by MAMTA-Health Institute for Mother and Child in collaboration with the Health Departments of Palam, New Delhi, and Rohtak, Haryana between 2015 and 2017. Data pertaining to the socio-economic and demographic information along with the information related to cervical cancer screening were utilized for the present study. The sample size was 1020 women in reproductive age group. Descriptive statistics (percentage and frequency distribution), bivariate analysis along with multivariable analysis were done to represent the results.  The Fisher exact test was used to test the level of significance during bivariate analysis.

resultsAbout 35.2% [Delhi: 44.9% and Rohtak: 23.8%] of the respondents had heard about cervical cancer screening. Further about 3.9% [Delhi-2.9% and Haryana-5.1%] had screened for cervical cancer. Women who had heard about cervical cancer were five times more likely to go for screening [aOR: 5.27; CI: 2.53,10.96]. It was found that women over 30 years of age had 12.04 significantly higher  odds of going for cervical cancer screening in reference to women aged 30 years and less [aOR: 12.04; CI: 3.01,53.20]. Women from households with a monthly income of more than 15000 had 2.98  significantly higher odds of going for cervical cancer screening in reference to women from households with an income of 5000 and less [aOR : 2.98; CI: 1.12,9.09].

conclusionFindings suggest that awareness about cervical cancer screening test along with its thorough knowledge about its benefits would be an effective intervention to increase the uptake of cervical cancer screening.

Indexed as

Uterine Cervical NeoplasmsAdultCross-Sectional StudiesEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHumansMass ScreeningPrevalencecervical cancer screeninghuman papillomavirusIndiaWomen

Identifiers

PMID36037133
PMCPMC9741889
OpenAlexW4293483973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.